|
CHORDC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.024400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.949200E-01 |
| Normal-vs-Stage2 |
1.529230E-01 |
| Normal-vs-Stage3 |
1.087610E-01 |
| Normal-vs-Stage4 |
1.042820E-01 |
| Stage1-vs-Stage2 |
1.044000E-01 |
| Stage1-vs-Stage3 |
1.085800E-01 |
| Stage1-vs-Stage4 |
1.043440E-01 |
| Stage2-vs-Stage3 |
8.207000E-01 |
| Stage2-vs-Stage4 |
3.156600E-01 |
| Stage3-vs-Stage4 |
3.248800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.910400E-02 |
| Normal-vs-AfricanAmerican |
5.541600E-01 |
| Normal-vs-Asian |
9.723500E-02 |
| Caucasian-vs-AfricanAmerican |
5.538200E-01 |
| Caucasian-vs-Asian |
8.824800E-03 |
| AfricanAmerican-vs-Asian |
6.661700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.120600E-01 |
| Normal-vs-Female |
3.197500E-02 |
| Male-vs-Female |
1.445950E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.440200E-01 |
| Normal-vs-Extreme_Weight |
8.810800E-01 |
| Normal-vs-Obese |
1.136850E-01 |
| Normal-vs-Extreme_Obese |
3.134600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.041400E-01 |
| Normal_Weight-vs-Obese |
7.682800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.386800E-01 |
| Extreme_Weight-vs-Obese |
9.284300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.707400E-01 |
| Obese-vs-Extreme_Obese |
8.519400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.644200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.097740E-02 |
| Normal-vs-Age(61-80Yrs) |
6.774000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.429700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.400230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.693900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.156200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.480200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.482280E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.723800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.402400E-01 |
| Normal-VS-Type2 PRCC |
7.204600E-01 |
| Normal-VS-KIRP CIMP |
7.398900E-03 |
| Normal-VS-Unclassified PRCC |
2.922200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.476000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.004470E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.407000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.338480E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.764400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.817400E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.357600E-01 |
| Normal-vs-N1 |
1.257500E-03 |
| Normal-vs-N2 |
1.217390E-01 |
| N0-vs-N1 |
2.216700E-03 |
| N0-vs-N2 |
2.582800E-01 |
| N1-vs-N2 |
6.543800E-02 |
|
|
